Health Tech Mohana Ravindranath STAT Plus: An investigation into Mindstrong’s unraveling, Cerebral layoffs, and DEA looks to restrict telehealth
Hospitals Tara Bannow STAT Plus: Ascension, Tufts fall short of financial targets in borrowing agreements
Special Report Mohana Ravindranath STAT Plus: How Mindstrong’s rush to roll out a ‘smoke alarm’ for mental illness led to its downfall
Hospitals Bob Herman and Tara Bannow STAT Plus: Hospital systems’ investment income perked up at end of 2022
Health Brittany Trang The FDA has cleared the first home flu and Covid test — but its maker just declared bankruptcy
Hospitals Bob Herman Patients still have no protection against surprise ambulance bills. And there’s no solution in sight
Health Tech Casey Ross STAT Plus: Verily, struggling to turn profits, taps a Starbucks veteran and ‘Warcraft’ master
Health Tech Matthew Herper STAT Plus: Top Verily executives depart amid leadership shakeup and layoffs
Biotech Adam Feuerstein, Damian Garde and Allison DeAngelis STAT Plus: SVB, biotech’s bank of choice, just failed. It could have ripple effects
Politics Joanne Silberner STAT Plus: Medicare will take R&D costs, effectiveness into account when it negotiates drug prices. But studies show that doesn’t affect prices
Health Tech Mohana Ravindranath STAT Plus: In Theranos’s backyard, a health tech leader takes another crack at better blood tests
Hospitals Bob Herman STAT Plus: In North Carolina, a small hospital deal poses big antitrust questions
Politics Rachel Cohrs STAT Plus: Medicare advisers suggest tweaks to coverage process for Alzheimer’s drugs
Politics Rachel Cohrs STAT Plus: Sen. Tammy Baldwin criticizes Ascension’s for-profit investment activities, requests returns and fees info
The Readout LOUD Damian Garde, Meg Tirrell and Adam Feuerstein Listen: Pharma blockbusters, pandemic policy, & legal chicanery
Health Tech Brittany Trang STAT Plus: Alphabet’s laid-off health tech employees on where their work heads next
Biotech Allison DeAngelis STAT Plus: Focused exclusively on life sciences, three top investors set out on their own
Hospitals Bob Herman STAT Plus: A different kind of ‘RAC’ subsidized hospitals’ labor during the pandemic
Biotech Allison DeAngelis STAT Plus: How one private biotech seized on JPM to emerge from stealth and tell its story
Biotech Allison DeAngelis STAT Plus: Biotech startups are hungry for dollars. Here’s what one pharma executive was looking for at JPM
Hospitals Tara Bannow STAT Plus: Medicare Advantage-focused Oak Street, Agilon Health chart out growth at J.P. Morgan
Business Tara Bannow STAT Plus: Study finds heavier reliance on nurse practitioners, physician assistants after private equity takeovers
Biotech Jonathan Wosen and Allison DeAngelis STAT Plus: A flurry of pharma acquisitions kick off JPM week after a slow year for deals
Business Bob Herman and Tara Bannow STAT Plus: The health care providers and insurers we’re watching at JPM23 — and why
Biotech Jonathan Wosen STAT Plus: Fate Therapeutics plans mass layoffs, after early end to cell therapy deal with Janssen
Health Tech Katie Palmer STAT Plus: Get care now, pay later?: Health care sees a surge in financing platforms for patients
Business Tara Bannow STAT Plus: Providers seeking resolution of billing disputes under the No Surprises Act cause a major backlog of cases
Biotech Damian Garde STAT Plus: Get ready for ‘the electric vehicles of biopharma’: Three biotech trends to watch in 2023